Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 公司前身为江阴采纳科技有限公司，由陆军、赵晓东两名自然人于2004年以货币方式出资设立，设立时注册资本为100万元。2004年7月23日，采纳有限在无锡市江阴工商行政管理局登记注册，取得注册号为3202812124332的《企业法人营业执照》。2017年6月23日，中汇会计师事务所（特殊普通合伙）出具“中汇会审（2017）4303号”《审计报告》，确认截至2017年3月31日，采纳有限账面净资产为83,794,134.41元。2017年7月3日，天源资产评估有限公司出具了“天源评报字（2017）第0238号”《评估报告》，确认截至2017年3月31日，采纳有限净资产评估值为10,032.07万元。2017年9月20日，采纳有限召开创立大会，通过了采纳科技成立事宜。2017年9月27日，公司在无锡市工商行政管理局办理了工商变更登记，并领取了编号为320200000201709270016的《营业执照》。 公司主要从事注射穿刺器械及实验室耗材的研发、生产和销售，通过ODM/OEM等方式为包括纽勤（Neogen）、麦朗（Medline）、赛默飞世尔（ThermoFisher）、麦克森（Mckesson）在内的全球知名企业提供穿刺针、注射器、实验室耗材等相关产品。公司注射穿刺器械按照产品适用对象的差异可分为兽用器械和医用器械，其中，兽用器械包括兽用注射针、注射器等穿刺注射器械，主要用于动物防治防疫的药液注射；医用器械包括各类一次性注射器、注射针、采血针、胰岛素注射器/针、导管类输注产品等医用耗材，主要适用于人体皮下、皮内、肌肉、静脉等注射或输注。公司实验室耗材主要包括培养皿、试剂管、细菌过滤盒等产品，用于对各类药品、食品、保健品（主要是液体类的）等微生物或细菌进行检测。公司目前主要产品为穿刺针、注射器、实验室耗材及口罩等，产品品种丰富。
Main Business 主要从事注射穿刺器械及实验室耗材的研发、生产和销售
Legal Representative 陆军
Top Executives
董事长：陆军
董事：侯鹏,程如法,查凌云,赵丽杰,赵红
独立董事：夏立扬,王尚虎,刘斌
Top 5 Shareholder
Shareholder name Nature Holding Date
陆军限售股28.29%30/06/2024
陆维炜限售股16.16%30/06/2024
赵红限售股6.38%30/06/2024
中信保诚人寿保险有限公司－分红自营流通A股5.85%30/06/2024
江阴市炜达尔企业管理中心（有限合伙）限售股5.32%30/06/2024
Company Secretary 陆维炜
Solicitors 北京德恒律师事务所
Auditors 中汇会计师事务所（特殊普通合伙）
Tel No 0510-86396766
Fax No 0510-86866666-8009
Website www.caina.ltd
Email ir@cainamed.com
Company Address
Register: 江苏省江阴市华士镇澄鹿路253号
Office: 江苏省江阴市华士镇澄鹿路253号
Listing Date 26/01/2022
Shares Capital
Shares Capital: 122,245,658
Total A Share: 122,245,658
Listed A Share: 44,245,658
Non-tradable A Share: 78,000,000
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.920
DPS(RMB)* ¥ 0.400
NBV Per Share(RMB)* ¥ 14.778
Market Capitalization(RMB) 0.692B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.